196 related articles for article (PubMed ID: 33061800)
1. Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in Hepatocellular Carcinoma.
Dong X; Feng M; Yang H; Liu H; Guo H; Gao X; Liu Y; Liu R; Zhang N; Chen R; Kong R
Int J Biol Sci; 2020; 16(15):2835-2852. PubMed ID: 33061800
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR.
Liu C; Zhang M; Zhao J; Zhu X; Zhu L; Yan M; Zhang X; Zhang R
Cancer Biother Radiopharm; 2020 May; 35(4):292-300. PubMed ID: 32191537
[No Abstract] [Full Text] [Related]
3. Actin binding LIM 1 (abLIM1) negatively controls osteoclastogenesis by regulating cell migration and fusion.
Narahara H; Sakai E; Yamaguchi Y; Narahara S; Iwatake M; Okamoto K; Yoshida N; Tsukuba T
J Cell Physiol; 2018 Jan; 234(1):486-499. PubMed ID: 29904924
[TBL] [Abstract][Full Text] [Related]
4. Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker.
Liu D; Wang X; Liu Y; Li C; Zhang Z; Lv P
Dis Markers; 2022; 2022():9516808. PubMed ID: 36583064
[TBL] [Abstract][Full Text] [Related]
5. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility.
Jin SH; Kim H; Gu DR; Park KH; Lee YR; Choi Y; Lee SH
BMB Rep; 2018 Jul; 51(7):356-361. PubMed ID: 29921413
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis.
Schmidt KM; Dietrich P; Hackl C; Guenzle J; Bronsert P; Wagner C; Fichtner-Feigl S; Schlitt HJ; Geissler EK; Hellerbrand C; Lang SA
Neoplasia; 2018 Dec; 20(12):1198-1208. PubMed ID: 30404068
[TBL] [Abstract][Full Text] [Related]
8. A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility.
Leung WK; Ching AK; Chan AW; Poon TC; Mian H; Wong AS; To KF; Wong N
Oncogene; 2011 Nov; 30(44):4464-75. PubMed ID: 21577206
[TBL] [Abstract][Full Text] [Related]
9. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
10. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
11. An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity.
Wei Y; Tang X; Ren Y; Yang Y; Song F; Fu J; Liu S; Yu M; Chen J; Wang S; Zhang K; Tan Y; Han Z; Wei L; Zhang B; Cheng Z; Li L; Wang H
Signal Transduct Target Ther; 2021 Dec; 6(1):421. PubMed ID: 34916485
[TBL] [Abstract][Full Text] [Related]
12. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
13. Rictor mediates p53 deactivation to facilitate the malignant transformation of hepatocytes and promote hepatocarcinogenesis.
Wang C; Kang H; Yi Y; Ding Y; Wang F; Luo J; Ye M; Hong Y; Xia C; Yan J; Liu L; Liu J; Zhong Z; Zhang Z; Zhao Q; Chang Y
J Transl Med; 2023 Dec; 21(1):919. PubMed ID: 38110956
[TBL] [Abstract][Full Text] [Related]
14. ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling.
He Y; Shi Q; Ling Y; Guo H; Fei Y; Wu R; Tang C; Zhang X; Yao L
Cell Death Differ; 2024 Feb; 31(2):203-216. PubMed ID: 38228802
[TBL] [Abstract][Full Text] [Related]
15. Hippocampus-specific Rictor knockdown inhibited 17β-estradiol induced neuronal plasticity and spatial memory improvement in ovariectomized mice.
Sun T; Liu Z; Liu M; Guo Y; Sun H; Zhao J; Lan Z; Lian B; Zhang J
Behav Brain Res; 2019 May; 364():50-61. PubMed ID: 30753873
[TBL] [Abstract][Full Text] [Related]
16. TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2.
Guo Z; Zhang X; Zhu H; Zhong N; Luo X; Zhang Y; Tu F; Zhong J; Wang X; He J; Huang L
Oncol Rep; 2021 Feb; 45(2):523-534. PubMed ID: 33416177
[TBL] [Abstract][Full Text] [Related]
17. Self-construction of actin networks through phase separation-induced abLIM1 condensates.
Yang S; Liu C; Guo Y; Li G; Li D; Yan X; Zhu X
Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2122420119. PubMed ID: 35858327
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha and beta regulate actin polymerization and spatial memory through an SRC-1/mTORC2-dependent pathway in the hippocampus of female mice.
Zhao Y; He L; Zhang Y; Zhao J; Liu Z; Xing F; Liu M; Feng Z; Li W; Zhang J
J Steroid Biochem Mol Biol; 2017 Nov; 174():96-113. PubMed ID: 28789972
[TBL] [Abstract][Full Text] [Related]
19. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Proteomics Implicates Rictor/mTORC2 in Cell Adhesion.
Wang H; Shao X; He Q; Wang C; Xia L; Yue D; Qin G; Jia C; Chen R
J Proteome Res; 2018 Oct; 17(10):3360-3369. PubMed ID: 30156101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
